Visible Genetics acquires HIV laboratory library
This article was originally published in Clinica
Executive Summary
Visible Genetics has bought privately-held diagnostics company Applied Sciences, and its library of over 200 drug resistant HIV strains, for $90,000 and 95,000 shares. As part of the deal Visible Genetics will inject $200,000 of working capital into the company.